Riskpilot← Back to searchSign inGet full accessSACCULUS AS
ASActiveOrg 991309616C/O Lillehammer Ønh Kirkegata 55, 2609 LillehammerMedical specialists activities · NACE 8622Est. 20071 employees
Revenue 2024
NOK 5,4M
+2% vs 2023
EBITDA margin
41.3%
+32% vs 2023
Equity ratio
96.2%
Financial strength
Net profit 2024
NOK 4M
+28% vs 2023
| Revenue | NOK 5,4M | +2% |
| EBITDA | NOK 2,2M | +32% |
| Net profit | NOK 4M | +28% |
| Total assets | NOK 20,5M | +8% |
| Equity | NOK 19,7M | +10% |
| Employees | 1 | — |
Legal name
SACCULUS AS
Org number
991309616
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
18. juni 2007
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legetjenester innen øre nese hals og virksomhet som naturlig hører sammen med dette, samt investering i og drift av fast eiendom og investering i aksjer og verdipapirer.
Address
C/O Lillehammer Ønh Kirkegata 55, 2609 Lillehammer
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 889 | 4 833 | 4 824 | 5 271 | 5 391 |
| Staff expenses | −1 005 | −1 039 | −1 019 | −1 027 | −1 163 |
| EBITDA | 1 854 | 1 661 | 1 672 | 1 683 | 2 225 |
| Depreciation & amort. | −3 | −17 | −40 | −37 | −25 |
| EBIT | 1 852 | 1 645 | 1 632 | 1 646 | 2 200 |
| Net financials | 1 946 | 982 | −759 | 1 863 | 2 311 |
| Profit before tax | 3 798 | 2 627 | 873 | 3 510 | 4 510 |
| Tax | 413 | 363 | 361 | 370 | 501 |
| Net profit | 3 385 | 2 264 | 512 | 3 139 | 4 009 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 13 887 | 15 799 | 16 125 | 18 977 | 20 484 |
| Equity | 13 187 | 15 051 | 15 243 | 17 982 | 19 711 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 700 | 748 | 882 | 995 | 773 |
| Total debt | 700 | 748 | 882 | 995 | 773 |
EBITDA margin
41.3%
This company
15.8%
Market median
+161% vs market
20202024
Equity ratio
96.2%
This company
38.2%
Market median
+152% vs market
20202024
Return on equity
20.3%
This company
18.4%
Market median
+10% vs market
20202024
Net profit margin
74.4%
This company
8.1%
Market median
+819% vs market
20202024
Asset turnover
0.26×
This company
1.12×
Market median
-77% vs market
20202024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TN Deputy Member | Deputy Member | 2007 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2007 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SACCULUS AS 
LILLEHAMMER ØRE-NESE-HALS ASBoard members of SACCULUS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Turid Nordbø | Deputy Member | 0 companies |
| Espen Kongelf | Chairman | 0 companies |